Table 2 Most reported adverse events in the AE-Sample (n = 4769) compared to the Swiss prescribing guidance
| Â | AE-Sample | Swiss prescribing guidance |
|---|---|---|
Total | 383 (8.0%) | Â |
Dizziness | 65 (1.4%) | >1% |
Nausea | 53 (1.1%) | >1% |
Headache | 43 (0.9%) | >1% |
Dyspepsia | 24 (0.5%) | 0.5–1% |
Diarrhea | 18 (0.4%) | 0.5–1% |
Palpitation | 17 (0.4%) | Not mentioned |
Cough | 15 (0.3%) | 0.5–1% |
Fatigue | 15 (0.3%) | >1% |
Vomiting | 11 (0.2%) | >1% |
Tachycardia | 10 (0.2%) | 0.5–1% |